Am J Transplant, Volume 19, Suppl 3 Archives - Page 48 of 214 - ATC Abstracts

2019 American Transplant Congress
Pharmacist Impact on Vaccinations Rates in Cardiothoracic Transplant Recipients
K. Zaborowski, J. Dedering, R. Felkner
William S. Middleton Memorial Veterans Hospital, Madison, WI
*Purpose: The purpose of this project is to determine the impact pharmacists have on cardiothoracic transplant recipients’ vaccination status at the time of transplant surgery.*Methods:…
2019 American Transplant Congress
Donor Derived Neoplasia: Will It Be a Risk after Clinical Pig Organ Xenotransplantation?
A. Jagdale¹, H. Iwase¹, E. Klein², D. Cooper¹
¹Surgery, University of Alabama at Birmingham, Birmingham, AL, ²Surgery, University of Pittsburgh, Pittsburgh, PA
*Purpose: The survival of the nonhuman primates with life-supporting pig kidney grafts has increased substantially (to >1 year). As clinical pig organ xenotransplantation draws closer,…
2019 American Transplant Congress
Infectious Complications after Treatment of Antibody-Mediated Kidney Allograft Rejection: A National Cohort Study
N. Perrottet¹, D. Golshayan², O. Manuel², V. Aubert², M. Koller³, K. Hadaya⁴, L. Bühler⁴, T. Mueller⁵, U. Huynh-Do⁶, S. Dahdal⁶, I. Binet⁷, M. Dickenmann³, S. Schaub³, J. Steiger³, M. Pascual², M. Fernández-Ruiz²
¹Pharmacy, CHUV, Lausanne, Switzerland, ²CHUV, Lausanne, Switzerland, ³USB, Basel, Switzerland, ⁴HUG, Geneva, Switzerland, ⁵USZ, Zurich, Switzerland, ⁶Inselspital, Bern, Switzerland, ⁷KSSG, St. Gallen, Switzerland
*Purpose: Multimodal therapeutic strategies used to treat acute antibody-mediated rejection (AMR) could enhance the risk of infection. However, data in this context are scarce.*Methods: We…
2019 American Transplant Congress
Favorable Outcome of Pathologic Downstaging by Locoregional Treatment for Hepatocellular Carcinoma in Liver Transplantation
D. Kim, J. Lee, S. Kim, K. In, D. Joo, S. Kim, M. Kim
Severance hospital, Seoul, Korea, Republic of
*Purpose: There was no distinct guideline how to take into account the effect of pretransplant locoregional treatment (LRT) in hepatocellular carcinoma (HCC) staging system. The…
2019 American Transplant Congress
Leukopenia at the Time of Liver Transplantation: Medication Tolerance and Clinical Outcomes
E. Tiao¹, J. Casale¹, J. LaMattina², S. Hammad¹
¹Pharmacy, University of Maryland Medical Center, Baltimore, MD, ²Surgery, University of Maryland School of Medicine, Baltimore, MD
*Purpose: Leukopenia post-orthotopic liver transplant (OLT) is associated with an increased incidence of infection and mortality. Prior to OLT, leukopenia may suggest innate immunosuppression and…
2019 American Transplant Congress
Cd45rb Mediates Cd8⁺T Cell Persistence In An Allogeneic Heterologous Immune Response
S. M. Krummey, A. B. Morris, M. L. Ford
Emory Transplant Center, Atlanta, GA
*Purpose: Memory T cells primed with microbial antigen can cross-react with alloantigen and mediate graft rejection, a process termed allogeneic heterologous immunity. Human and murine…
2019 American Transplant Congress
A Video Intervention to Increase Organ Donor Registration (ODR) at the Department of Motorized Vehicles (DMV)
D. A. DuBay¹, T. Morinelli¹, D. Redden², N. Ivankova², I. Herbey³, C. L. Holt⁴, L. Siminoff⁵, M. Fouad², Z. Su⁶, M. Martin⁷
¹Surgery, Medical University of South Carolina`, Charleston, SC, ²University of Alabama at Birmingham, Birmingham, AL, ³Surgery, University of Alabama at Birmingham, Birmingham, AL, ⁴University of Maryland, College Park, MD, ⁵Temple University, Philadelphia, PA, ⁶Medical University of South Carolina`, Charleston, SC, ⁷University of Tennessee Health Sciences Center, Memphis, TN
*Purpose: To implement a sustainable, low cost DMV-based intervention that increased ODR of DMV patrons, and secondarily, increase ODR in African Americans (AAs).*Methods: Results from…
2019 American Transplant Congress
Insurance Status Impacts Treatment for Hepatocellular Carcinoma
L. Sobotka¹, A. Hinton², L. Conteh¹
¹Gastroenterology, Hepatology and Nutrition, The Ohio State Wexner Medical Center, Columbus, OH, ²The Ohio State University, Columbus, OH
*Purpose: Previous studies have identified treatment disparities in the treatment of hepatocellular carcinoma (HCC) based on insurance status and provider. Recent studies have shown more…
2019 American Transplant Congress
Healthcare Resource Utilization and Associated Costs of Cytomegalovirus Management among Solid Organ Transplant Recipients
W. Y. Cheng¹, P. Thompson-Leduc¹, H. Cheung¹, R. Avery², T. Bo³, S. Chavan³, M. Duh¹, I. Hirji³
¹Analysis Group, Inc., Boston, MA, ²Johns Hopkins University, Baltimore, MD, ³Shire, Cambridge, MA
*Purpose: Solid organ transplant (SOT) recipients who develop cytomegalovirus (CMV) infection and disease are at increased risk of morbidity. We quantified real-world healthcare resource utilization…
2019 American Transplant Congress
Direct Oral Anticoagulants: An Evaluation of the Safety and Efficacy in Solid Organ Transplant Recipients
T. Pasley, A. Logan, A. Brueckner, L. Bowman, A. Silverman, A. Rumore
Tampa General Hospital, Tampa, FL
*Purpose: The use of direct oral anticoagulants (DOACs) has not been fully adopted by the solid organ transplant (SOT) community due to factors including, fluctuating…